FDA Plan Seeks Better, Not Burdensome, Data Collection, McClellan Says
Executive Summary
FDA Commissioner McClellan's strategic plan for the agency envisions "better," not "burdensome," information collection to inform risk management decisions
You may also be interested in...
FDA Patient Safety Strategy Would Shift AE Monitoring To Automated Systems
FDA plans to unveil a broad patient safety strategy over the next few months that will explain how the agency plans to move away from reliance on voluntary reporting to use of automated systems to collect adverse event and medical errors data
FDA Medical Error Proposal Requires Reporting “Near-Misses” Within 15 Days
FDA's proposed safety reporting requirements would require reports on "near misses" of medical errors within 15 days
FDA Bar Code Proposal Requires NDC; Lot, Expiration Date Not Cost Effective
FDA's proposed bar code rule does not require that the lot number or expiration date be encoded on product packaging because it has not been shown to be cost effective